Organon & Co. is listed on the NYSE as (NYSE:OGN). What is Organon & Co.'s stock symbol? Organon & Co.'s stock symbol is OGN and currently trades under NYSE. Future Index. · Barron's · Market Data; /; Stocks; /; OGN; /; Financials. Organon & Co. U.S.: NYSE. Follow. after hours. $. Due Diligence Checks · OGN ($) is trading below its intrinsic value of $, according to an updated version of Benjamin Graham's Formula from Chapter About Organon & Co. Stock (NYSE:OGN) Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices. Organon Stock forecast & analyst price target predictions based on 4 analysts offering months price targets for OGN in the last 3 months (NYSE: OGN) to.
Get Organon & Co (OGN.N) real-time stock quotes, news, price and financial Traders work on the floor of the NYSE in New York · US consumer prices. View today's Organon & Co stock price and latest OGN news and analysis. Create real-time notifications to follow any changes in the live stock price. Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. View today's Organon & Co stock price and latest OGN news and analysis. Create real-time notifications to follow any changes in the live stock price. (NYSE: OGN) Organon & Co's forecast annual earnings growth rate of % is not forecast to beat the US Drug Manufacturers - General industry's average forecast. OGN - Organon & Co. (NYSE) - Share Price and News. Organon & Co. NEW YORK STOCK EXCHANGE INC. (%). Last Update Aug 23, , PM EDT. Organon (NYSE:OGN): Underappreciated Healthcare Stock with a % Dividend Yield. 2M ago. OGN. Organon, Shanghai Henlius Biotech: EMA validates MAAs for HLX Discover real-time Organon & Co. Common Stock (OGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. (NYSE:OGN). Organon & Co. 4. NYSE:OGN (USA) Ordinary Shares. $ + (+3%) PM EST. Organon & Co. (NYSE:OGN) Q2 Earnings Call Transcript August 6, AM ET Company Participants Jennifer Halchak - Head of IR Kevin Ali -. ORGANON & CO. NYSE. ++%. High Low VolM. Closed 08/07 EDT. Chart. News. Press Releases. Financial Reports. Profile.
Find the latest Organon & Co. Common Stock (OGN) annual income statements, balance sheets, financial statements, ratios, and cash flow data at esportday.online Organon & Co OGN:NYSE ; Close. quote price arrow up + (+%) ; Volume. 1,, ; 52 week range. - Get Organon & Co (OGN.N) real-time stock quotes, news, price and financial on the floor at the NYSE in. Site Index. Latest. Home · Authors · Topic sitemap. Organon & Co. (NYSE:OGN) Q2 Earnings Call Transcript August 6, AM ET Company Participants Jennifer Halchak - Head of IR Kevin Ali -. About OGN. Facts Insights Learn. Organon & Co. is a science based global (NYSE:OGN): Underappreciated Healthcare Stock with a % Dividend Yield by. Organon & Co OGN:NYSE. Last Price, Today's Change, Today's Volume. $, + (%), 2,, Above Avg. As of close 08/23/ Summary; News; Charts. Organon (NYSE:OGN): Underappreciated Healthcare Stock with a % Dividend Yield. 2M ago. OGN. Organon, Shanghai Henlius Biotech: EMA validates MAAs for HLX Less than $1/wk. Sign In. PROFILE. Organon. NYSE: OGN. Jersey City, New Jersey. $ + (+%). Share Price. as of August 30 PM EST. FORBES. Organon & Co (NYSE:OGN) Intrinsic Valuation. Check if OGN is overvalued or undervalued under the bear, base, and bull scenarios of the company's future.
Check if OGN Stock has a Buy or Sell Evaluation. OGN Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Organon & Co. News. View Organon & Co. OGN stock quote prices, financial information, real-time forecasts, and company news from CNN. (OGN). Organon & Co. (OGN). (%) 08/20/24 [NYSE]. x OGN: (%). Dollars and Wallets - Holding money bunched in fist. OGN - Organon & Co. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE). View the Organon & Co:NYSE stock price chart to see a history of performance, stock value, timeline of financial events and indicators for a full analysis.
Organon (NYSE: OGN) has expanded its agreement with Eli Lilly to become the sole distributor and promoter for the migraine medicine Emgality® (galcanezumab). NYSE: OGN ; Price. $ Change. + ; Volume. 1,, % Change. +% ; Intraday High. $ 52 Week High. $